NIH Funding · FY2024
Total Funding
$1M
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#15,017
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $1M across 1 grant · National rank #15017.
Top grants by award amount
Mallikarjun Sundaram Srivatsan's NIH grant portfolio, ranked by award amount.
- 4R44CA287806-02R44Preclinical and IND enabling studies for treatment of advanced lung cancer and other cancers metastatic to lung by pulmonary delivery of engineered Influenza A Virus (eIAV)$1Maward amount
Affiliation
Institutions that have administered grants for Mallikarjun Sundaram Srivatsan.
Affiliated with Accurius Therapeutics, Inc. (MA).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardAccurius Therapeutics, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
Explore further
Find collaborators for Mallikarjun Sundaram Srivatsan
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Accurius Therapeutics, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →